Nimrata Hunt, PhD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nimrata Hunt, PhD
Idexx Laboratories Inc /De reported in an 8-K filed March 26, 2026 that Nimrata Hunt, PhD was appointed Special Advisor, effective April 13, 2026. Idexx Laboratories Inc /De reported in an 8-K filed March 26, 2026 that Nimrata Hunt, PhD was terminated as Executive Vice President, Global Strategy and Commercial, effective April 13, 2026.
“You and the Company agree that you will continue your employment with IDEXX as a Special Advisorfrom the Separation Date through July 13, 2026 (the “Final Employment Date”, and such period between the Separation Date andthe Final Employment Date, the “Advisory Period”).”
“On March 24, 2026, IDEXX Laboratories, Inc. (“IDEXX”) and Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, mutually agreed that Dr. Hunt will cease serving in her current role effective on April 13, 2026 (the “Separation Date”) and will continue to provide advisory services on an as-needed basis until July 13, 2026 (the “Final Employment Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2026-04-13–2026-04-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.